bluebird bio
BLUE
$0.92
Share price
1.13%
Change (1 day)
-78.79%
Change (1 year)
EPS for bluebird bio (BLUE)
EPS in 2023 (TTM): -$1.02
According to bluebird bio 's latest financial reports the company's current EPS (TTM) is -$1.02. In 2022 the company made an earnings per share (EPS) of -$3.58 an increase over its 2021 EPS that were of -$11.95.
EPS history for bluebird bio from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.02 | -71.51% |
| 2022 | -$3.58 | -70.04% |
| 2021 | -$11.95 | 20.1% |
| 2020 | -$9.95 | -30.47% |
| 2019 | -$14.31 | 34.11% |
| 2018 | -$10.67 | 39.3% |
| 2017 | -$7.66 | 8.5% |
| 2016 | -$7.06 | 47.08% |
| 2015 | -$4.80 | 169.66% |
| 2014 | -$1.78 | -40.95% |
| 2013 | -$3.01 | 380.01% |
| 2012 | -$0.63 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $3.18 | -411.79% | 🇫🇷 France |
 Merck MRK | $1.82 | -278.60% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | -$1.44 | 41.18% | 🇺🇸 USA |
 GlycoMimetics
GLYC | -$0.65 | -36.27% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.78 | -176.34% | 🇺🇸 USA |